Do small increases in serum ferritin impact prognosis in lower-risk MDS patients?

Int J Hematol. 2020 May;111(5):742-744. doi: 10.1007/s12185-020-02848-3. Epub 2020 Mar 9.

Anacelia Gomes de Matos Mota^{1

2}, Priscila da Silva Mendonça^{3

4

5}, Howard Lopes Ribeiro Junior^{3

4

6}, Ana Patrícia Nogueira Aguiar^{3

4}, Ronald Feitosa Pinheiro^{3

4

7}, Silvia Maria Meira Magalhães^{3

4

7}

¹ Cancer Cytogenomic Laboratory, Post‑graduate Program in Medical Science, Federal University of Ceara, Rua Coronel Nunes de Melo, 1000 ‑ 2° andar‑ Rodolfo Teófilo, Fortaleza, CE, 60430‑275, Brazil. anaceliagomesm@yahoo.com.br.
² Post-Graduate Program in Medical Science, Federal University of Ceara, Fortaleza, Brazil. anaceliagomesm@yahoo.com.br.
³ Cancer Cytogenomic Laboratory, Post‑graduate Program in Medical Science, Federal University of Ceara, Rua Coronel Nunes de Melo, 1000 ‑ 2° andar‑ Rodolfo Teófilo, Fortaleza, CE, 60430‑275, Brazil.
⁴ Post-Graduate Program in Medical Science, Federal University of Ceara, Fortaleza, Brazil.
⁵ Walter Cantidio University Hospital, Federal University of Ceara, EBSERH, Fortaleza, Brazil.
⁶ Post-Graduate Program in Translational Medicine. Drug Research and Development Center, Federal University of Ceara, Fortaleza, Ceara, Brazil.
⁷ Department of Clinical Medicine, Federal University of Ceara, Fortaleza, Brazil.

No abstract available

Publication types